Adam Jeffery Partner Content Partner Content IQVIA Introduces Orchestrated Customer Engagement to Europea... BARCELONA, SPAIN and LONDON, UK, 13th March 2018 – Today at the eyeforpharma congress, IQVIA (NYSE:IQV) introduces its new Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents. Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017. Partner Content Partner Content What oncologists need from you when launching a new therapy At the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is no surprise that two-years on, the number of therapeutic options in cancer care is growin Load more results
Partner Content Partner Content IQVIA Introduces Orchestrated Customer Engagement to Europea... BARCELONA, SPAIN and LONDON, UK, 13th March 2018 – Today at the eyeforpharma congress, IQVIA (NYSE:IQV) introduces its new
Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.
Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.
Partner Content Partner Content What oncologists need from you when launching a new therapy At the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is no surprise that two-years on, the number of therapeutic options in cancer care is growin
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
